Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)


$2.9800
-0.0200 ( -1.06% ) 5.7K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open


$2.9800

Previous close


$3.0000

Volume


5.7K

Market cap


$202.76M

Day range


$3.0100 - $3.1750

52 week range


$2.2800 - $19.0500

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Apr 08, 2024
8-k 8K-related 15 Apr 03, 2024
8-k 8K-related 16 Mar 28, 2024
10-k Annual reports 124 Mar 28, 2024
8-k 8K-related 14 Mar 25, 2024
8-k 8K-related 117 Mar 19, 2024
4 Insider transactions 1 Mar 08, 2024
8-k 8K-related 103 Mar 08, 2024
8-k 8K-related 22 Mar 06, 2024
8-k 8K-related 104 Feb 05, 2024

Latest News